Combining CD27 and CD134(OX40) stimulation with PD-L1 Blockade is beneficial to recovering exhausted T cell function

In a mouse adoptive adoptive transfer T cell exhaustion model improved T cell proliferation was observed when agonistic antibodies against CD27 and CD134 were included with the CD274 blockade.  “OX40- and CD27-Mediated Costimulation Synergizes with Anti-PD-L1 Blockade by Forcing Exhausted CD8+ T Cells to Exit Quiescence” Sarah L. Buchan, Aymen Al-Shamkhani, Ronjon Chakraverty, et al.  […]

Combining CD27 and CD134(OX40) stimulation with PD-L1 Blockade is beneficial to recovering exhausted T cell function Read More »

Oxidized Low Density Lipoprotein-Immune complexes linked to the Severity of Retinopathy in Type II Diabetes Patients

oxLDL-IC pathology was mediated by CD36 and CD64 receptors on retinal pericytes.  “Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes.” D Fu, T J Lyons, et al. (May, 2014) J Lipid Res 55: 860-869.  PMID: 24616481 Ancell reagents were used in this study to selectively block IC

Oxidized Low Density Lipoprotein-Immune complexes linked to the Severity of Retinopathy in Type II Diabetes Patients Read More »

CD39 and CD161 are useful markers for observing Th17 inflammatory T cell response.

Level of CD4+CD39+/CD161+ T cell sub population in muscosal membranes and peripheral blood correlate to severity of Crohns Disease.  “CD39 and CD161 Modulate Th17 Responses in Crohn’s Disease” A Bai, S C Robson, et al. (2014) J Immunol 193(7): 3366-3377. PMID:25172498 Relevant Ancell antibodies and conjugates anti-human CD4 anti-human CD39 anti-human CD161

CD39 and CD161 are useful markers for observing Th17 inflammatory T cell response. Read More »

anti-CD326 antibodies now available

Human CD326 (EpCAM, EGP2, HEA) is a 40kD glycoprotein expressed on epithelial cells and many carcinomas.  It is an adhesion molecule whose function is implicated in carcinogenesis and erythropoesis. CD326 has great potential as a therapeutic and diagnostic marker for cancer (2, 3). 1) Rao CG, et al. (2005) Int. J. Oncol  27: 49 2)

anti-CD326 antibodies now available Read More »